The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals, metals and antioxidants in oxidative stress-induced cancer
Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.009 · Cited by 6,680
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Principles and Practice of Screening for Disease.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-5-1085_2 · Cited by 3,066
Janero, D. R. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90131-2 · Cited by 2,722
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
Bast, R. C., Klug, T. L., John, E. S., Jenison, E., Niloff, J. M., Lazarus, H., Berkowitz, R. S., Leavitt, T., Griffiths, C. T., Parker, L., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198310133091503 · Cited by 2,135
Role of oxygen radicals in DNA damage and cancer incidence
Valko, M., Izakovic, M., Mazur, M., Rhodes, C. J., & Telser, J. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000049134.69131.89 · Cited by 1,820
The Role of Oxidative Stress in Carcinogenesis
Klaunig, J. E., & Kamendulis, L. M. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121851 · Cited by 1,533
Principles and Practice of Screening for Disease.
Zavon, M. R. (1969) · Archives of Internal Medicine · doi:10.1001/archinte.1969.00300130131020 · Cited by 1,356
PIK3CA is implicated as an oncogene in ovarian cancer
Shayesteh, L., Lu, Y., Kuo, W.-L., Baldocchi, R., Godfrey, T., Collins, C., Pinkel, D., Powell, B., Mills, G. B., & Gray, J. W. (1999) · Nature Genetics · doi:10.1038/5042 · Cited by 1,155
Anderson, N. L., Polanski, M., Pieper, R., Gatlin, T., Tirumalai, R. S., Conrads, T. P., Veenstra, T. D., Adkins, J. N., Pounds, J. G., Fagan, R., et al. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300127-mcp200 · Cited by 1,006
[Principles and practice of mass screening for disease].
Wilson, J. M., & Jungner, Y. G. (1968) · PubMed · Cited by 1,004
Principles and Practice of Gynecologic Oncology
Hoskins, W. J., Pérez, C. A., & Young, R. C. (1992) · Cited by 945
Zhang, Z., Bast, R. C., Yu, Y., Li, J., Sokoll, L. J., Rai, A. J., Rosenzweig, J. M., Cameron, B., Wang, Y. Y., Meng, X.-Y., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0746 · Cited by 934
Role of oxygen free radicals in cancer development
Dreher, D., & Junod, A. F. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00531-5 · Cited by 855
Principles and Practice of Gynecologic Oncology
Moore, W. (1997) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199707000-00022 · Cited by 838
The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.
Hellström, I., Raycraft, J., Hayden-Ledbetter, M. S., Ledbetter, J. A., Schummer, M., McIntosh, M. W., Drescher, C. W., Urban, N. D., & Hellström, K. E. (2003) · PubMed · Cited by 813
Lysophosphatidic Acid as a Potential Biomarker for Ovarian and Other Gynecologic Cancers
Xu, Y. (1998) · JAMA · doi:10.1001/jama.280.8.719 · Cited by 637
Kabawat, S. E., Bast, R. C., Bhan, A. K., Welch, W. R., Knapp, R. C., & Colvin, R. B. (1983) · International Journal of Gynecological Pathology · doi:10.1097/00004347-198303000-00005 · Cited by 588
Ovarian Cancer: Screening, Treatment, and Follow-up
Seltzer, V. (1995) · JAMA · doi:10.1001/jama.1995.03520300065039 · Cited by 580
Screening for ovarian cancer: a pilot randomised controlled trial
Jacobs, I. J., Skates, S. J., MacDonald, N., Menon, U., Rosenthal, A. N., Davies, A. P., Woolas, R., Jeyarajah, A. R., Sibley, K., Lowe, D. G., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10261-1 · Cited by 560
(1992) · Journal of Diagnostic Medical Sonography · doi:10.1177/875647939200800127 · Cited by 551
Clinical proteomics: translating benchside promise into bedside reality
Petricoin, E. F., Zoon, K. C., Kohn, E. C., Barrett, J. C., & Liotta, L. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd891 · Cited by 550
Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer
Kim, J.-H. (2002) · JAMA · doi:10.1001/jama.287.13.1671 · Cited by 480
Progress and Challenges in Screening for Early Detection of Ovarian Cancer
Jacobs, I. J., & Menon, U. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r400006-mcp200 · Cited by 458
Lu, K. H., Patterson, A. P., Wang, L., Marquez, R. T., Atkinson, E. N., Baggerly, K. A., Ramoth, L. R., Rosen, D. G., Liu, J., Hellstrom, I., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0409 · Cited by 440
Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer.
Fedarko, N. S., Jain, A., Karadağ, A., Eman, M. R. V., & Fisher, L. W. (2001) · PubMed · Cited by 380
Jacobs, I., Davies, A. P., Bridges, J., Stabile, I., Fay, T., Lower, A., Grudzinskas, J. G., & Oram, D. (1993) · BMJ · doi:10.1136/bmj.306.6884.1030 · Cited by 360
Proteomic Patterns in Biological Fluids: Do They Represent the Future of Cancer Diagnostics?
Diamandis, E. P. (2003) · Clinical Chemistry · doi:10.1373/49.8.1272 · Cited by 324
Characterization of serum biomarkers for detection of early stage ovarian cancer
Kozak, K. R., Su, F., Whitelegge, J. P., Faull, K., Reddy, S., & Farias‐Eisner, R. (2005) · PROTEOMICS · doi:10.1002/pmic.200500093 · Cited by 311
Self-citationGranberg, S., Wikland, M., & Jansson, I. (1989) · Gynecologic Oncology · doi:10.1016/0090-8258(89)90031-0 · Cited by 301
Cancer Incidence by Levels of Cholesterol
Williams, R. R., Sorlie, P. D., Feinleib, M., McNamara, P. M., Kannel, W. B., & Dawber, T. R. (1981) · JAMA · doi:10.1001/jama.1981.03310280023021 · Cited by 289
Kozak, K. R., Amneus, M. W., Pusey, S. M., Su, F., Luong, M. N., Luong, S. A., Reddy, S. T., & Farias-Eisner, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2033602100 · Cited by 276
Self-citationZurawski, V. R., Orjaseter, H., Andersen, A., & Jellum, E. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420507 · Cited by 268
Ye, B., Cramer, D. W., Skates, S. J., Gygi, S. P., Pratomo, V., Fu, L., Horick, N., Licklider, L., Schorge, J. O., Berkowitz, R. S., et al. (2003) · PubMed · Cited by 267
Lerner, J. P., Timor-Tritsch, I. E., Federman, A., & Abramovich, G. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(13)70284-9 · Cited by 261
High-resolution serum proteomic features for ovarian cancer detection.
Conrads, T. P., Fusaro, V. A., Ross, S., Johann, D., Rajapakse, V, Hitt, B. A., Steinberg, S. M., Kohn, E. C., Fishman, D. A., Whitely, G., et al. (2004) · Endocrine-related cancer · doi:10.1677/erc.0.0110163 · Cited by 260
Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter
Modesitt, S. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(03)00670-7 · Cited by 258
Skates, S. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.955 · Cited by 256
Bourne, T. H., Campbell, S., Reynolds, K. M., Whitehead, M. I., Hampson, J., Royston, P., Crayford, T. J., & Collins, W. P. (1993) · BMJ · doi:10.1136/bmj.306.6884.1025 · Cited by 240
Oxidative Stress, DNA Damage, and Breast Cancer
Kang, D.-H. (2002) · AACN Clinical Issues: Advanced Practice in Acute and Critical Care · doi:10.1097/00044067-200211000-00007 · Cited by 221
Wulfkuhle, J. D., Aquino, J. A., Calvert, V. S., Fishman, D. A., Coukos, G., Liotta, L. A., & Petricoin, E. F. (2003) · PROTEOMICS · doi:10.1002/pmic.200300591 · Cited by 221
Proteomic Approaches to Tumor Marker Discovery
Rai, A. J., Zhang, Z., Rosenzweig, J., Shih, I.-M., Pham, T., Fung, E. T., Sokoll, L. J., & Chan, D. W. (2002) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2002-126-1518-pattmd · Cited by 219
The Malignant Potential of Small Cystic Ovarian Tumors in Women over 50 Years of Age
Bailey, C. L., Ueland, F. R., Land, G. L., DePriest, P. D., Gallion, H. H., Kryscio, R. J., & van Nagell, J. R. (1998) · Gynecologic Oncology · doi:10.1006/gyno.1998.4965 · Cited by 197
Valentin, L. (1999) · Ultrasound in Obstetrics & Gynecology · doi:10.1046/j.1469-0705.1999.14050338.x · Cited by 179
Ferrazzi, E., Zanetta, G., Dordoni, D., Berlanda, N., Mezzopane, R., & Lissoni, G. (1997) · Ultrasound in Obstetrics & Gynecology · doi:10.1046/j.1469-0705.1997.10030192.x · Cited by 172
Timmerman, D., Bourne, T. H., Tailor, A., Collins, W. P., Verrelst, H., Vandenberghe, K., & Vergote, I. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70436-9 · Cited by 159
Skates, S. J., Pauler, D. K., & Jacobs, I. J. (2001) · Journal of the American Statistical Association · doi:10.1198/016214501753168145 · Cited by 149
CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients
Høgdall, E. V. S., Christensen, L. H., Kjær, S. K., Blaakær, J., Kjærbye‐Thygesen, A., Gayther, S. A., Jacobs, I. J., & Høgdall, C. K. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.09.028 · Cited by 144
Stein, S. M., Laifer‐Narin, S., Johnson, M. B., Roman, L. D., Muderspach, L. I., Tyszka, J. M., & Ralls, P. W. (1995) · American Journal of Roentgenology · doi:10.2214/ajr.164.2.7839975 · Cited by 133
Nustad, K., Bast, R. C., Brien, T. J. O. R., Nilsson, O., Seguin, P., Suresh, M. R., Saga, T., Nozawa, S., Børmer, O. P., de Bruijn, H. W. A., et al. (1996) · Tumor Biology · doi:10.1159/000217982 · Cited by 133
Analysis of the human serum proteome
Chan, K. C., Lucas, D. A., Hise, D., Schaefer, C. F., Xiao, Z., Janini, G. M., Buetow, K. H., Issaq, H. J., Veenstra, T. D., & Conrads, T. P. (2004) · Clinical Proteomics · doi:10.1385/cp:1:2:101 · Cited by 114
Suzuki, S., Moore, D. H., Ginzinger, D. G., Godfrey, T. E., Barclay, J., Powell, B., Pinkel, D., Zaloudek, C. J., Lu, K., Mills, G. B., et al. (2000) · PubMed · Cited by 111
Iron status and risk of cardiovascular disease
Corti, M., Gaziano, J. M., & Hennekens, C. H. (1997) · Annals of Epidemiology · doi:10.1016/s1047-2797(96)00112-3 · Cited by 110
Distinguishing the Benign and Malignant Adnexal Mass: An External Validation of Prognostic Models
Mol, B. W., Boll, D., Kanter, M. D., Heintz, A. P. M., Sijmons, E. A., Oei, S. G., Bal, H., & Brölmann, H. A. M. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.6052 · Cited by 109
Lloyd, K. O., Yin, B. W. T., & Kudryashov, V. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970529)71:5<842::aid-ijc24>3.0.co;2-8 · Cited by 108
Osteopontin as an Adjunct to CA125 in Detecting Recurrent Ovarian Cancer
Schorge, J. O., Drake, R. D., Lee, H., Skates, S. J., Rajanbabu, R., Miller, D. S., Kim, J., Cramer, D. W., Berkowitz, R. S., & Mok, S. C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0365 · Cited by 108
Surveillance of women at high risk for hereditary ovarian cancer is inefficient
Oei, A. L. M., Massuger, L. F. A. G., Bulten, J., Ligtenberg, M. J., Hoogerbrugge, N., & de Hullu, J. A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603015 · Cited by 100
Prospective Study of Serum CA-125 Levels as Markers of Ovarian Cancer
Helzlsouer, K. J. (1993) · JAMA · doi:10.1001/jama.1993.03500090059033 · Cited by 97
Glutathione loading prevents free radical injury in red blood cells after storage
Dumaswala, U. J., Wilson, M. J., Wu, Y. L., Wykle, J., Zhuo, L., Douglass, L. M., & Daleke, D. L. (2000) · Free Radical Research · doi:10.1080/10715760000301061 · Cited by 87
Profiling of Protein Kinases in the Neoplastic Transformation of Human Ovarian Surface Epithelium
Wong, A. S. T., Kim, S. O., Leung, P. C. K., Auersperg, N., & Pelech, S. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6280 · Cited by 76
Zhang, Z., Barnhill, S. D., Zhang, H., Xu, F., Yu, Y., Jacobs, I. J., Woolas, R. P., Berchuck, A., Madyastha, K. R., & Bast, R. C. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5320 · Cited by 76
Validation of Candidate Serum Ovarian Cancer Biomarkers for Early Detection
Su, F., Lang, J. M., Kumar, A., Ng, C. J., Hsieh, B., Suchard, M. A., Reddy, S. T., & Farias‐Eisner, R. (2007) · Biomarker Insights · doi:10.1177/117727190700200011 · Cited by 73
Self-citationPerformance of ultrasound as a second line test to serum CA125 in ovarian cancer screening
Menon, U., Talaat, A. S., Rosenthal, A. N., MacDonald, N., Jeyerajah, A. R., Skates, S. J., Sibley, K., David, H., & Jacobs, I. J. (2000) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb11685.x · Cited by 71
Bosse, K., Rhiem, K., Wappenschmidt, B., Hellmich, M., Madeja, M., Ortmann, M., Mallmann, P. K., & Schmutzler, R. K. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.06.032 · Cited by 63
Kenemans, P., van Kamp, G. J., Oehr, P., & Verstraeten, R. A. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.12.2509 · Cited by 61
Ovarian cancer tumor marker behavior in asymptomatic healthy women: implications for screening.
Crump, C., McIntosh, M. W., Urban, N. D., Anderson, G. L., & Karlan, B. Y. (2000) · PubMed · Cited by 53
Plasma Prealbumin in Women with Epithelial Ovarian Carcinoma
Mählck, C. ‐., & Grankvist, K. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000292542 · Cited by 47
Loss of cellular retinol-binding protein 1 gene expression in microdissected human ovarian cancer.
Cvetković, D., Williams, S. J., & Hamilton, T. C. (2003) · PubMed · Cited by 46
Serum lipids concentration in women with benign and malignant ovarian tumours
Gadomska, H., Grzechocińska, B., Janecki, J., Nowicka, G., Powolny, M., & MARIANOWSKI, L. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.02.045 · Cited by 39
Feasibility Study of a Randomised Trial of Ovarian Cancer Screening among the General Population
Parkes, C. A., Smith, D., Wald, N., & Bourne, T. (1994) · Journal of Medical Screening · doi:10.1177/096914139400100404 · Cited by 37
An integrated approach utilizing proteomics and bioinformatics to detect ovarian cancer
Yu, J., Zheng, S. S., Tang, Y., & Li, L. (2005) · Journal of Zhejiang University. Science A · doi:10.1631/jzus.2005.b0227 · Cited by 36
Pre-operative prediction of serum CA125 level in women with ovarian masses.
Benjapibal, M., & Neungton, C. (2007) · PubMed · Cited by 27
Chechlińska, M., Kaminska, J. A., Markowska, J., Kramar, A., & Steffen, J. A. (2007) · The International Journal of Biological Markers · doi:10.1177/172460080702200302 · Cited by 21
Is Three-Dimensional Power Doppler Ultrasound Better Than Two-Dimensional Power Doppler?
Guerriero, S., AJOSSA, S., & Melis, G. B. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2001.6510 · Cited by 11
Cited by
Hennessy, B. T., Coleman, R. L., & Markman, M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61338-6 · Cited by 640
CA125 and Ovarian Cancer: A Comprehensive Review
Charkhchi, P., Cybulski, C., Gronwald, J., Wong, F. O., Narod, S. A., & Akbari, M. R. (2020) · Cancers · doi:10.3390/cancers12123730 · Cited by 602
Cell surface protein glycosylation in cancer
Christiansen, M. N., Chik, J., Lee, L., Anugraham, M., Abrahams, J. L., & Packer, N. H. (2014) · PROTEOMICS · doi:10.1002/pmic.201300387 · Cited by 518
Clarke-Pearson, D. L. (2009) · New England Journal of Medicine · doi:10.1056/nejmcp0901926 · Cited by 400
Biomarkers in Cancer Detection, Diagnosis, and Prognosis
Das, S., Dey, M. K., Devireddy, R., & Gartia, M. R. (2023) · Sensors · doi:10.3390/s24010037 · Cited by 383
Metadata
- Authors
- Nossov, V., Amneus, M., Su, F., Lang, J., Janco, J. M. T., Reddy, S. T., & Farias-Eisner, R.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 199
- Issue
- 3
- Pages
- 215-223
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W2026542164
- Cited by
- 291
- References
- 74
- FWCI
- 24.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.